目的:观察对60例臀上皮神经炎患者采用超声引导下针刀配合冲击波治疗的临床疗效。方法:回顾性分析在2022年12月到2023年12月期间,60例采用超声引导下针刀配合冲击波治疗臀上皮神经炎的患者。对治疗前、首次疗程后及治疗结束3周后疼痛模...目的:观察对60例臀上皮神经炎患者采用超声引导下针刀配合冲击波治疗的临床疗效。方法:回顾性分析在2022年12月到2023年12月期间,60例采用超声引导下针刀配合冲击波治疗臀上皮神经炎的患者。对治疗前、首次疗程后及治疗结束3周后疼痛模拟视觉量表(VAS)评分、日本骨科协会腰部功能评分表(JOA)、超声下臀上皮神经卡压部位横径数值、空腹血清疼痛介质水平进行比较分析,统计临床有效率评定患者的临床疗效。结果:患者疗程结束后3周VAS评分为(2.21 ± 1.25)分,JOA评分为(25 ± 1.58)分,超声下臀上皮神经卡压部位横径数值为(1.39 ± 0.68) mm,疼痛介质水平5-HT为(0.23 ± 0.034) μmol/L、PGE2为(418.35 ± 26.39) ng/L、Cor为(84.85 ± 4.26) ng/mL、ACTH为(37.07 ± 3.26) pg/mL,比治疗前及首个疗程后均有较大改善,临床有效率为91.67%,差异均有统计学意义(P Objective: To observe the clinical effect of ultrasound-guided acupotomy combined with shockwave therapy on 60 patients with gluteal epithelial neuritis. Methods: A retrospective analysis of 60 patients treated with ultrasound-guided acupotomy combined with shockwave therapy for gluteal epithelial neuritis was performed between December 2022 and December 2023. Before treatment, after the first course of treatment and 3 weeks after the end of treatment, the score of pain Analog Visual Scale (VAS), the Japanese Orthopaedic Association Lumbar Function Rating Scale (JOA), the transverse diameter of the hip epithelial nerve compression site under ultrasound, and the level of fasting serum pain mediators were compared and analyzed, and the clinical effective rate was statistically evaluated. Result: The VAS score and JOA score of the patient were (2.21 ± 1.25) and (25 ± 1.58) respectively at 3 weeks after treatment. The transverse diameter of the entrapage site of the gluteal epithelial nerve under ultrasound was (1.39 ± 0.68) mm. Pain mediators were 5-HT (0.23 ± 0.034) μmol/L, PGE2 (418.35 ± 26.39) ng/L, Cor (84.85 ± 4.26) ng/mL, ACTH (37.07 ± 3.26) pg/mL. Compared with before and after the first course of treatment, the clinical effective rate was 91.67%, and the differences were statistically significant (P < 0.05). Conclusion: Ultrasound-guided needle-knife combined with shockwave therapy for gluteal neuritis has the advantages of visualization and precise localization, and is a safe and effective treatment method worthy of clinical promotion.展开更多
目的从基因分子水平探讨酒精性骨质疏松(alcoholic osteoporosis,AOP)大鼠的发病机制,观察生髓健骨胶囊对AOP大鼠骨密度(bone mineral density,BMD)、骨矿含量(bone mineral content,BMC)表达的影响,探讨生髓健骨胶囊对AOP大鼠模型的中...目的从基因分子水平探讨酒精性骨质疏松(alcoholic osteoporosis,AOP)大鼠的发病机制,观察生髓健骨胶囊对AOP大鼠骨密度(bone mineral density,BMD)、骨矿含量(bone mineral content,BMC)表达的影响,探讨生髓健骨胶囊对AOP大鼠模型的中药防治作用机理。方法选取成年雄性(清洁级)SD大鼠120只,称体重,随机分为4组,每组各30只,用白酒灌胃法造模,同时分别给予生理盐水、碳酸钙阿法D3、生髓健骨胶囊灌胃给药。于造模8、12、16周末取材,检测股骨上端BMD、BMC指标。结果检测造模干预8、12、16周后BMD、BMC指标变化,模型组BMD、BMC与正常组比较明显降低,且差异有统计学意义(P<0.01),结果表明饮酒大鼠确实存在骨量减少,BMD、BMC降低;中药干预组BMD、BMC与模型组相比显著升高(P<0.01);中药干预组BMD、BMC与西药对照组相比,明显升高(P<0.05)。结论通过观察生髓健骨胶囊对AOP大鼠的实验指标,证明了生髓健骨胶囊能够提高AOP大鼠骨密度,增加骨矿含量,抑制矿物质丢失,改善大鼠的骨代谢。展开更多
目的:观察分析冲击波配合针刀治疗跖腱膜炎型跟痛症(plantar fasciitis type of calcaneodynia)的临床疗效。方法:选取符合纳入标准的患者90例,将其随机分为采取冲击波治疗的患者30例、针刀治疗的患者30例、冲击波配合针刀治疗的患者30...目的:观察分析冲击波配合针刀治疗跖腱膜炎型跟痛症(plantar fasciitis type of calcaneodynia)的临床疗效。方法:选取符合纳入标准的患者90例,将其随机分为采取冲击波治疗的患者30例、针刀治疗的患者30例、冲击波配合针刀治疗的患者30例,分析患者治疗后1、4、12周时的VAS评分和AOFAS评分变化。结果:运用SPSS20.0对数据进行单因素方差分析:(1)治疗前VAS评分比较,F=0.24,P=0.79,差异不具有统计学意义[(6.92±0.66)、(7.03±0.59)、(7.01±0.61)]。治疗后的组间VAS评分对比,F=15.82,P<0.01,冲击波配合针刀治疗组治疗效果明显优于针刀治疗组和冲击波治疗组,针刀治疗组治疗效果优于冲击波治疗组,组间均具有显著差异,差异具有统计学意义[(3.30±1.85)、(1.61±1.72)、(0.98±1.00)];(2)治疗前AOFAS评分比较,差异不具有统计学意义[(62.66±2.29)、(61.86±1.80)、(61.96±1.84),F=1.34,P=0.26]。3组患者治疗后AOFAS评分,组间均具有显著差异,冲击波配合针刀治疗组治疗效果明显优于针刀治疗组和冲击波治疗组,针刀治疗组治疗效果优于冲击波治疗组,差异具有统计学意义[(77.28±8.04)、(83.68±7.09)、(91.72±5.93),F=28.49,P<0.01]。结论:冲击波配合针刀疗法能有效解除跖腱膜的高应力状态,缓解局部组织的紧张、挛缩,使足底恢复正常的生物力学平衡从而达到治疗跖腱膜炎型跟痛症的目的。展开更多
文摘目的:观察对60例臀上皮神经炎患者采用超声引导下针刀配合冲击波治疗的临床疗效。方法:回顾性分析在2022年12月到2023年12月期间,60例采用超声引导下针刀配合冲击波治疗臀上皮神经炎的患者。对治疗前、首次疗程后及治疗结束3周后疼痛模拟视觉量表(VAS)评分、日本骨科协会腰部功能评分表(JOA)、超声下臀上皮神经卡压部位横径数值、空腹血清疼痛介质水平进行比较分析,统计临床有效率评定患者的临床疗效。结果:患者疗程结束后3周VAS评分为(2.21 ± 1.25)分,JOA评分为(25 ± 1.58)分,超声下臀上皮神经卡压部位横径数值为(1.39 ± 0.68) mm,疼痛介质水平5-HT为(0.23 ± 0.034) μmol/L、PGE2为(418.35 ± 26.39) ng/L、Cor为(84.85 ± 4.26) ng/mL、ACTH为(37.07 ± 3.26) pg/mL,比治疗前及首个疗程后均有较大改善,临床有效率为91.67%,差异均有统计学意义(P Objective: To observe the clinical effect of ultrasound-guided acupotomy combined with shockwave therapy on 60 patients with gluteal epithelial neuritis. Methods: A retrospective analysis of 60 patients treated with ultrasound-guided acupotomy combined with shockwave therapy for gluteal epithelial neuritis was performed between December 2022 and December 2023. Before treatment, after the first course of treatment and 3 weeks after the end of treatment, the score of pain Analog Visual Scale (VAS), the Japanese Orthopaedic Association Lumbar Function Rating Scale (JOA), the transverse diameter of the hip epithelial nerve compression site under ultrasound, and the level of fasting serum pain mediators were compared and analyzed, and the clinical effective rate was statistically evaluated. Result: The VAS score and JOA score of the patient were (2.21 ± 1.25) and (25 ± 1.58) respectively at 3 weeks after treatment. The transverse diameter of the entrapage site of the gluteal epithelial nerve under ultrasound was (1.39 ± 0.68) mm. Pain mediators were 5-HT (0.23 ± 0.034) μmol/L, PGE2 (418.35 ± 26.39) ng/L, Cor (84.85 ± 4.26) ng/mL, ACTH (37.07 ± 3.26) pg/mL. Compared with before and after the first course of treatment, the clinical effective rate was 91.67%, and the differences were statistically significant (P < 0.05). Conclusion: Ultrasound-guided needle-knife combined with shockwave therapy for gluteal neuritis has the advantages of visualization and precise localization, and is a safe and effective treatment method worthy of clinical promotion.
文摘目的从基因分子水平探讨酒精性骨质疏松(alcoholic osteoporosis,AOP)大鼠的发病机制,观察生髓健骨胶囊对AOP大鼠骨密度(bone mineral density,BMD)、骨矿含量(bone mineral content,BMC)表达的影响,探讨生髓健骨胶囊对AOP大鼠模型的中药防治作用机理。方法选取成年雄性(清洁级)SD大鼠120只,称体重,随机分为4组,每组各30只,用白酒灌胃法造模,同时分别给予生理盐水、碳酸钙阿法D3、生髓健骨胶囊灌胃给药。于造模8、12、16周末取材,检测股骨上端BMD、BMC指标。结果检测造模干预8、12、16周后BMD、BMC指标变化,模型组BMD、BMC与正常组比较明显降低,且差异有统计学意义(P<0.01),结果表明饮酒大鼠确实存在骨量减少,BMD、BMC降低;中药干预组BMD、BMC与模型组相比显著升高(P<0.01);中药干预组BMD、BMC与西药对照组相比,明显升高(P<0.05)。结论通过观察生髓健骨胶囊对AOP大鼠的实验指标,证明了生髓健骨胶囊能够提高AOP大鼠骨密度,增加骨矿含量,抑制矿物质丢失,改善大鼠的骨代谢。
文摘目的:观察分析冲击波配合针刀治疗跖腱膜炎型跟痛症(plantar fasciitis type of calcaneodynia)的临床疗效。方法:选取符合纳入标准的患者90例,将其随机分为采取冲击波治疗的患者30例、针刀治疗的患者30例、冲击波配合针刀治疗的患者30例,分析患者治疗后1、4、12周时的VAS评分和AOFAS评分变化。结果:运用SPSS20.0对数据进行单因素方差分析:(1)治疗前VAS评分比较,F=0.24,P=0.79,差异不具有统计学意义[(6.92±0.66)、(7.03±0.59)、(7.01±0.61)]。治疗后的组间VAS评分对比,F=15.82,P<0.01,冲击波配合针刀治疗组治疗效果明显优于针刀治疗组和冲击波治疗组,针刀治疗组治疗效果优于冲击波治疗组,组间均具有显著差异,差异具有统计学意义[(3.30±1.85)、(1.61±1.72)、(0.98±1.00)];(2)治疗前AOFAS评分比较,差异不具有统计学意义[(62.66±2.29)、(61.86±1.80)、(61.96±1.84),F=1.34,P=0.26]。3组患者治疗后AOFAS评分,组间均具有显著差异,冲击波配合针刀治疗组治疗效果明显优于针刀治疗组和冲击波治疗组,针刀治疗组治疗效果优于冲击波治疗组,差异具有统计学意义[(77.28±8.04)、(83.68±7.09)、(91.72±5.93),F=28.49,P<0.01]。结论:冲击波配合针刀疗法能有效解除跖腱膜的高应力状态,缓解局部组织的紧张、挛缩,使足底恢复正常的生物力学平衡从而达到治疗跖腱膜炎型跟痛症的目的。